DrugPatentWatch Database Preview

CELECOXIB Drug Profile

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Celecoxib, and when can generic versions of Celecoxib launch?

Celecoxib is a drug marketed by Alembic Pharms Ltd, Amneal Pharms, Apotex Inc, Aurobindo Pharma Ltd, Cipla Ltd, Cspc Ouyi Pharm Co, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan Pharms Inc, Teva, Torrent Pharms Ltd, and Watson Labs Inc. and is included in fourteen NDAs.

The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the celecoxib profile page.

Summary for CELECOXIB

US Patents:	0
Applicants:	14
NDAs:	14
Suppliers / Packagers:	42
Bulk Api Vendors:	114
Clinical Trials:	411
Patent Applications:	5,121
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CELECOXIB
DailyMed Link:	CELECOXIB at DailyMed

Pharmacology for CELECOXIB

Ingredient-type	Nonsteroidal Anti-inflammatory Compounds
Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for CELECOXIB

Cyclooxygenase 2 Inhibitors

Synonyms for CELECOXIB

169590-42-5

184007-95-2

194044-54-7

1oq5

4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE

4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide

4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole

590C425

A25046

AB00052396_10

AB00052396_11

AB00052396-07

AB00052396-08

AB00052396-09

AB0012055

ABP000291

AC-4228

AC1L1E6K

ACT02648

AI-525

AKOS015842517

AM84588

AN-12211

AT-3762

BBL029086

BC209720

BCP9000507

BCPP000290

BDBM11639

Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-

benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-

Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)

BIDD:GT0408

BP-30217

BRD-K02637541-001-02-4

BSPBio_003596

C-6317

C07589

C17H14F3N3O2S

CAS-169590-42-5

CCG-39354

CCRIS 8679

CCRIS 9330

Celebra

Celebra (TN)

Celebrex

Celebrex (TN)

Celebrex, Celebra, 169590-42-5

Celebrex, Celebra, Celecoxib

Celecox

Celecoxi

Celecoxib (JAN/USAN/INN)

Celecoxib (SC-58635)

Celecoxib [Old RN]

Celecoxib [USAN]

Celecoxib 1.0 mg/ml in Acetonitrile

Celecoxib, >=98% (HPLC)

Celecoxib, European Pharmacopoeia (EP) Reference Standard

Celecoxib, pharmaceutical secondary standard; traceable to USP, PhEur

Celecoxib, United States Pharmacopeia (USP) Reference Standard

Celecoxib/Celebrex, Celebra

Celecoxib|169590-42-5|Celebrex|SC 58635

Celecoxibum

Celocoxib

CEP-33222

CHEBI:41423

CHEMBL118

cid_2662

CJ-016377

cMAP_000027

CP-598107

CPD000550473

CS-0570

CTK8H4475

D00567

D03RTS

DB00482

DivK1c_000893

DSSTox_CID_2777

DSSTox_GSID_22777

DSSTox_RID_76725

DTXSID0022777

EBD24636

Eurocox

EX-A175

FT-0080064

FT-0601628

FT-0623536

FT-0700357

GTPL2892

HE065764

HE317467

HMS1922G14

HMS2089L18

HMS2093I07

HMS2234N18

HMS3259L08

HMS3261A14

HMS3373A09

HMS3654H09

HMS502M15

HSDB 7038

HY-14398

I01-1033

IDI1_000893

J-010566

J-520011

J10035

JCX84Q7J1L

KB-76000

KBio1_000893

KBio2_000912

KBio2_002351

KBio2_003480

KBio2_004919

KBio2_006048

KBio2_007487

KBio3_002830

KBio3_003037

KBioGR_000723

KBioGR_002351

KBioSS_000912

KBioSS_002354

KS-00000FW2

KS-1041

LS-31667

MCULE-4750749400

Medicoxib

MFCD00941298

MLS001165684

MLS001195656

MLS001304708

MLS006011862

MolPort-002-885-815

NC00708

NCGC00091455-01

NCGC00091455-02

NCGC00091455-03

NCGC00091455-04

NCGC00091455-05

NCGC00091455-06

NCGC00091455-07

NCGC00091455-08

NCGC00091455-09

NCGC00254540-01

NCGC00259513-01

NCGC00261091-01

NCI60_041049

NINDS_000893

NSC-719627

NSC-758624

NSC719627

NSC758624

Onsenal

Onsenal (TN)

p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide

PF-00345549

Pfizer brand of celecoxib

PHA-00846533

Pharmakon1600-01503678

Q-200816

RL02184

RZEKVGVHFLEQIL-UHFFFAOYSA-N

s1261

SAM002589995

SBI-0051875.P002

SC 58635

SC-50829

SC-58553, SC-58635

SC-58635

SC58635

SCHEMBL3708

SMR000550473

Solexa

SPBio_001512

Spectrum_000432

SPECTRUM1503678

Spectrum2_001576

Spectrum3_001996

Spectrum4_000182

Spectrum5_001324

SR-01000837528

SR-01000837528-2

STL373576

SYN3015

TL8001323

Tox21_111135

Tox21_111135_1

Tox21_201964

Tox21_300599

Tox21_500406

TPI-336

UNII-JCX84Q7J1L

UNM-0000305813

US8741944, Comparative Compound

Xilebao

YM 177

YM-177

YM177

Z2210694606

ZINC2570895

US Patents and Regulatory Information for CELECOXIB

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Pharms Inc	CELECOXIB	celecoxib	CAPSULE;ORAL	078857-003	Feb 11, 2015	AB	RX	No	No
Macleods Pharms Ltd	CELECOXIB	celecoxib	CAPSULE;ORAL	204590-002	Mar 16, 2016	AB	RX	No	No
Torrent Pharms Ltd	CELECOXIB	celecoxib	CAPSULE;ORAL	207677-003	Dec 23, 2015	AB	RX	No	No
Teva	CELECOXIB	celecoxib	CAPSULE;ORAL	076898-003	May 30, 2014	AB	RX	No	No

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans